EP2480408A1 - Structures composites de fibres et de mousse, et procédés de fabrication - Google Patents

Structures composites de fibres et de mousse, et procédés de fabrication

Info

Publication number
EP2480408A1
EP2480408A1 EP10819437A EP10819437A EP2480408A1 EP 2480408 A1 EP2480408 A1 EP 2480408A1 EP 10819437 A EP10819437 A EP 10819437A EP 10819437 A EP10819437 A EP 10819437A EP 2480408 A1 EP2480408 A1 EP 2480408A1
Authority
EP
European Patent Office
Prior art keywords
foam
fiber composite
composite material
material according
fibers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10819437A
Other languages
German (de)
English (en)
Other versions
EP2480408A4 (fr
Inventor
Chandrasiri Jayakody
Alison J. Kimmitz
Geoffrey M. Stoltz
Chad M. Bannan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Essentra Porous Technologies Corp
Original Assignee
Filtrona Porous Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/887,943 external-priority patent/US20110070423A1/en
Application filed by Filtrona Porous Technologies Corp filed Critical Filtrona Porous Technologies Corp
Publication of EP2480408A1 publication Critical patent/EP2480408A1/fr
Publication of EP2480408A4 publication Critical patent/EP2480408A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/22—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed
    • B32B5/24—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer
    • B32B5/26—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer another layer next to it also being fibrous or filamentary
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
    • B29C44/02—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles for articles of definite length, i.e. discrete articles
    • B29C44/12—Incorporating or moulding on preformed parts, e.g. inserts or reinforcements
    • B29C44/1209—Incorporating or moulding on preformed parts, e.g. inserts or reinforcements by impregnating a preformed part, e.g. a porous lining
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/0085—Use of fibrous compounding ingredients
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
    • D06M23/04—Processes in which the treating agent is applied in the form of a foam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2250/00—Layers arrangement
    • B32B2250/20—All layers being fibrous or filamentary
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2260/00—Layered product comprising an impregnated, embedded, or bonded layer wherein the layer comprises an impregnation, embedding, or binder material
    • B32B2260/02—Composition of the impregnated, bonded or embedded layer
    • B32B2260/021—Fibrous or filamentary layer
    • B32B2260/023—Two or more layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2260/00—Layered product comprising an impregnated, embedded, or bonded layer wherein the layer comprises an impregnation, embedding, or binder material
    • B32B2260/04—Impregnation, embedding, or binder material
    • B32B2260/046—Synthetic resin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2266/00—Composition of foam
    • B32B2266/02—Organic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2266/00—Composition of foam
    • B32B2266/02—Organic
    • B32B2266/0207—Materials belonging to B32B25/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2266/00—Composition of foam
    • B32B2266/02—Organic
    • B32B2266/0214—Materials belonging to B32B27/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2266/00—Composition of foam
    • B32B2266/02—Organic
    • B32B2266/0214—Materials belonging to B32B27/00
    • B32B2266/0221—Vinyl resin
    • B32B2266/0235—Vinyl halide, e.g. PVC, PVDC, PVF, PVDF
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2266/00—Composition of foam
    • B32B2266/02—Organic
    • B32B2266/0214—Materials belonging to B32B27/00
    • B32B2266/0278—Polyurethane
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2266/00—Composition of foam
    • B32B2266/06—Open cell foam
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2266/00—Composition of foam
    • B32B2266/08—Closed cell foam
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2307/00—Properties of the layers or laminate
    • B32B2307/70—Other properties
    • B32B2307/728—Hydrophilic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2555/00—Personal care
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2556/00—Patches, e.g. medical patches, repair patches
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2375/04—Polyurethanes

Definitions

  • the invention relates generally to reinforced foam structures and, more specifically, to fiber-reinforced composite materials having increased durability and utility in fields such as personal care and medical care, particularly in the area of wound care.
  • foam materials include, but are not limited to, polyurethane foam, polyvinyl chloride foam, polyimide foam, silicone foam, or latex foam.
  • a different approach has been to take an existing matrix structure (e.g., a network of fibers) and embed shreds of previously formed foam material throughout the structure.
  • the purpose of this approach is to make use of the strength properties of the matrix structure, but impart it with properties (e.g., hydrophilicity) of the foam material.
  • the foam material has little or no structural integrity of its own.
  • An aspect of the present invention provides a foam-fiber composite material comprising a monolithic foam structure comprising a polymer material and a fiber web comprising a plurality of fibers disposed substantially throughout the foam structure.
  • Another aspect of the present invention provides a method of forming a foam- fiber composite material.
  • the method comprises providing a web of fibers having a loft and a basis mass and providing a polymer foam precursor comprising a plurality of reactants.
  • the method further comprises dispensing the polymer foam precursor onto the web of fibers and forcing penetration of the polymer foam precursor into and through the web of fibers.
  • the method still further comprises allowing the polymer foam precursor reactants to react to form a monolithic foam structure having the plurality of fibers disposed throughout.
  • the present invention provides composite materials comprising a continuous monolithic foam material throughout which is disposed a network or web of fibers.
  • the fiber network may be disposed so as to provide reinforcement to the foam structure substantially through its entire extent.
  • the distribution of the fibers within the foam structure may be homogeneous or heterogeneous.
  • the fiber distribution may be systematically varied throughout the foam structure.
  • different regions within the foam structure may have different fiber distributions, each of which may be homogeneous or heterogeneous. In the alternative or in addition, the fibers within these regions may have different fiber characteristics.
  • the foam-fiber composite materials of the invention may be produced using a highly efficient, continuous production line.
  • the process involves mixing the polymer foam reactants and immediately depositing the mixture onto a continuous web of fibers.
  • the reactant mixture is forced into and through the fiber web. This may be accomplished using a nip roll or other doctoring tool, passage through which produces a sheet having a uniform thickness.
  • the combined mixture/fiber web swells to form the final thickness of the composite material.
  • the foam-fiber composites of the invention typically exhibit improved tensile strength and tear strength. They may also be structured to provide porosity or capillarity gradients through the material by the establishment of multiple cross-sectional regions having different fiber characteristics or distributions.
  • a significant aspect of the invention is that the continuous manufacturing process used to produce the foam-fiber composite materials of the invention allows for mass- manufacturing in an inexpensive and efficient manner. It will be understood by those of ordinary skill in the art that this process may be used to manufacture composite materials using a wide variety of foam materials and fiber webs/fabrics. However, the foam-fiber composite materials may be either hydrophobic or hydrophilic.
  • the foam-fiber composite material disclosed herein may be used in many applications, including long-term wound care, negative pressure wound therapy, cosmetics, and various cleaning applications.
  • the composite material comprises a highly absorbent foam with hydrophilic properties and that is structurally enhanced by the fibers distributed throughout the foam.
  • foam-fiber composite materials of the invention will now be described in more detail.
  • any foam material may be used to form the foam- fiber composite materials of the invention including but not limited to polyurethane, silicone foam dispersions, latex foam dispersions and other polymeric systems.
  • Polyurethane foams may be either open-cell or closed-cell and may be produced via reaction of any of a variety of polyisocyanates, crosslinking agents, surfactants, and polyols, and may use a catalyst and a blowing agent or pressurized gas. Blowing agents may include water or other auxiliary blowing agents commonly used in polyurethane foam production such as acetone, liquid carbon dioxide, ethyl acetate, hydrocarbons, fluorinated hydrocarbons.
  • a hydrophilic, open cell polyurethane foam may be produced through a two step prepolymer-based method.
  • the first step involves a reaction of polyisocyanate and a polyol to create a prepolymer with a stoichiometric excess of isocyanate groups.
  • a crosslinker can also be added to create branching, thereby improving the physical characteristics of the hydrophilic foam.
  • the second step involves a further reaction between the prepolymer and an aqueous solution.
  • the aqueous solution may contain surfactants, colorants, antimicrobials, vitamins, controlled release agents and other like additives discussed below.
  • the reaction between the prepolymer and the aqueous solution produces an open-celled, hydrophilic polyurethane foam, which may be used in a variety of applications, including, but not limited to, spot pressure relieving foams for respirator masks, foams for wound care applications, cosmetic applicator foams, and the like.
  • Polyisocyanates useful in making prepolymers that can be used to produce foam structures for use in the invention include toluene diisocyanate (TDI) in the form of 2,4- and 2,6- isomers in the ratio of 80:20 or 65:35, diphenylmethane diisocyanate (MDI), polymeric diphenylmethane diisocyanate (PMDI), a mixture of various isomers of diphenylmethane diisocyanate, a mixture of TDI and MDI, isopherone diisocyanate (IPDI), dicyclohexylmethane- 4,4'-diisocyanate (Hi 2 MDI), 1 ,6-hexamethylene diisocyanate (HDI), polyaryl polymethylene polyisocyanate (PAPI), ethylene diisocyanate, cyclohexylene-l ,2-diisocyante, cyclohexylene- 1 ,4-di
  • Polyols that may be used in this invention include polyether polyols, polyester polyols (for example, polycaprolactone), polyoxyalkylene polyols (for example, polyoxyethylene polyols), oxyethylene-oxypropylene block copolymer polyols, polyols with hydroxyl
  • Crosslinkers that may be used in this invention include propylene glycol, 1 ,2- butanediol, 1,3-butanediol, 1 ,4-butanediol, trimethylene glycol, trimethylolpropane,
  • trimethylolethane glycerol, pentaerythritol, sucrose, triethanolamine, triisopropanolamine, resorcinol, ethylene diamine, propylene diamine, catechol, and the like.
  • Off-the-shelf prepolymers that can be used to produce polyurethane foams in various embodiment of the invention include such products as PrePol (Filtrona Porous
  • the aqueous solution used to produce the foam structure of the invention may be water or an emulsion of water and surfactants.
  • aqueous emulsions that may be used include, but are not limited to, polyvinyl alcohols, vinyl acetate, polyvinyl acetates, polyvinylidene chlorides, polyvinylchloride latex, silicone emulsions including SM 2138 (from Momentive Performance Materials), polychloroprene latex, acrylonitrile, SBR latex, NBR latex, carboxylated copolymer latex, acrylic latex, and other lattices, acrylic acid ester polymers or copolymers, or other polymeric systems.
  • the amount of aqueous solution or latex or silicone emulsion as a percentage of the prepolymer may be upwards of 500% or even higher.
  • the latex and silicone emulsions are particularly useful in yielding viscoelastic type foams that can be incorporated into fiber composite materials.
  • a non-aqueous solution may also be used to produce the foam structure of the invention, and may be a mixture of polyoxyalkylene polyol, a surfactant, a blowing agent, and a catalyst.
  • the aqueous or non-aqueous solutions may optionally include various additives, some of which are intended to be released from, others of which are intended to remain in, the foam-fiber composite material when the material is exposed to a certain environment and/or applied to a certain substrate (e.g., as a wound care dressing).
  • the releasable additives may be or include volatile ingredients and/or bioactive additives including, but not limited to, antimicrobials, antibiotics, vitamins such as vitamin E, silver or silver derivatives, lubricants, biologicals, pharmaceuticals, bactericides, botanicals, cosmetic ingredients, perfumes, detergents, soaps, disinfectants, solid particles, emollients, volatiles, and other like additives.
  • the releasable additives may comprise controlled-release mechanisms or structures that serve to control the timing or duration of release of the releasable additive for interaction with another material or surface.
  • the unreleasable additives may be or include blood clotting agents such as chitosan, flame retardants, cosmetic ingredients, colorants, waxes, superabsorbent polymers, cellulosic polymers, solid particles, and other like additives.
  • the releasable or unreleasable additives described above may be incorporated into the foam-fiber composite material by mixing with the prepolymer component of the foam instead of or in addition to the aqueous component.
  • the relative amount of releasable or unreleasable additives that can be added will depend on the specific foam materials and the nature and desired use of the additive. Typically, however, the amount of the releasable or unreleasable additive will be in a range of 0.0001 percent to about 80 percent by weight of the dry foam material.
  • any foam material may be used to form the composite materials of the invention.
  • the foam material it is desirable that the foam material be biodegradable.
  • the product may be biodegradable if both components (foam and fiber) are hydrolytically unstable, and therefore would undergo degradation under aqueous conditions.
  • Exemplary biodegradable foams that may be used in the invention may be produced by making the prepolymer with any of various degradable polyesters (i.e., instead of polyethers) and aliphatic diisocyanates such as Desmodur® W (H 12 MDI) (instead of aromatic TDI, MDI).
  • Open cell hydrophilic foams made in the above manner have several advantages, including superior water absorption and purity levels. This makes them valuable for stringent medical applications. Unreinforced foams of this type do, however, have several disadvantages: they tend to swell significantly when wet, have relatively poor tensile and tear strength when dry, and have even poorer tensile and tear strength when wet. They also have a relatively
  • homogeneous, or isotropic, pore structure which means that they may not be configured to contain a gradient of porosity or capillarity, which would serve to move or pull liquid from one side of the foam construction to the other in a variable, but controlled, manner.
  • the composite materials of the invention overcome the above-described disadvantages through the incorporation of fibers throughout the foam structure.
  • the fiber network of the foam-fiber composite materials of the invention may be or comprise virtually any woven or non-woven fiber web.
  • the fibers themselves may be comprised of synthetic or natural polymers or may be non-polymeric. If polymeric, the fibers may be any of a variety of fiber types including extruded fibers, monocomponent fibers, multicomponent fibers, melt-blown fibers, wet-spun fibers, dry-spun fibers, bonded fibers, natural fibers, and the like.
  • the composition of the fibers may include any thermoplastic or thermoset polymeric material, including but not limited to, cellulose acetate, other acetates and esters of cellulose, virgin or regenerated cellulose, polyamides, such as nylons, including nylon 6 and nylon 66; polyolefins, such as polyethylene and polypropylene; polyesters including polyethylene terephthalate and polybutylene terephthalate; polyvinyl chloride; polymers of ethylene methacrylic acid, ethylene acrylic acid, ethylene vinyl acetate, or ethylene methyl acrylate; polystyrene; polysulfones; polyphenylene sulfide; polyacetals; acrylics and polymers comprising blocks of polyethylene glycol; as well as copolymers and derivatives of all of the foregoing.
  • polyamides such as nylons, including nylon 6 and nylon 66
  • polyolefins such as polyethylene and polypropylene
  • polyesters including polyethylene terephthalate and polybut
  • Biodegradable polymeric materials that may be used include polycaprolactone (PCL), polyglycolide (PGA), polylactide (PLA), polyaramides, natural fibers (e.g. cotton, wool), and the like.
  • PCL polycaprolactone
  • PGA polyglycolide
  • PLA polylactide
  • Paramides polyaramides
  • natural fibers e.g. cotton, wool
  • Non-organic fibers such as carbon fibers, glass fibers and mineral fibers may also be used.
  • the fiber webs used in the invention may be provided in a variety of forms. For example, they may be provided in bulked or un-bulked form. Any or all of the fibers may be provided as bonded or unbonded webs of staple or continuous fibers (e.g., filaments or tows).
  • the fiber web may be comprised in the form of a woven or non-woven fabric. In a non-woven fabric, the fibers may, in some embodiments, be thermally, chemically, or mechanically (e.g., by needle punching, hydro entanglement, embossing, and the like) bonded to one another at spaced apart points of contact.
  • the fibers may be formed and collected using any of the methods disclosed in U.S. Pat. Nos. 5,607,766; 6, 103, 181 ; and 7,290,668 and U.S. Pat. App. No.
  • the fiber portion of foam-fiber composite materials are provided in the form of non-woven sheets of polymeric staple fibers.
  • Such non-woven materials have proven advantageous in the manufacturing process and in yielding improved physical properties of the final foam-fiber composite.
  • the non-woven sheets may be made by one of a number of different methodologies and can have high loft, or thickness, or can be "flat" ( i.e., have a very low loft).
  • non-woven textiles When formed of either hydrophilic fibers or fibers featuring a hydrophilic surface finish, non-woven textiles have absorbency properties that make them particularly suitable for certain medical applications. (Non-woven polyester rayon constructions, for example, are widely used in wound care applications as bandage media (e.g., gauze)).
  • the foam-fiber composite materials of the invention may be formed by a continuous manufacturing process in which a continuous fiber web provides a matrix into which an as-yet unreacted or only partially reacted polymer foam precursor is introduced. When the polymer reacts (or as it continues to react) to form the cells of the foam structure, it expands throughout the fiber matrix. As has been discussed, a goal of the method is to produce a composite in which the fiber matrix extends substantially throughout the foam material. It has been found, however, that this may be accomplished only through the use of certain criteria to match the amount and nature of the foam material to characteristics of the fiber web such as its loft, thickness, density and porosity.
  • the roll gap of the nip roller and the flow rate of the polymer foam precursor should be set so that the resulting thickness of the foam component is approximately equal to the initial thickness of the fiber web prior to indoctrination of the precursor into the web. This tends to assure that the fibers of the web are completely distributed throughout the foamed material in a rapid manner. In effect, the foam and fiber matrix is created upon pouring and then immediately passed through a nip roller gap. Composite materials produced in this manner exhibited improved tensile and tear strength compared to native (unreinforced) foam.
  • the manufacturing process involves preparing a polymer foam precursor (e.g., by mixing a prepolymer with an aqueous solution) in a mix head. If any releasable or unreleasable additives are to be included they may be added to one or both of the constituents (i.e., the prepolymer or the aqueous solution) prior to combining the materials in the mix head or may be added separately into the mixture.
  • the polymer foam precursor is then deposited onto a fiber web via a mix head. As discussed above, the fiber web may be in the form of a woven or non-woven fabric.
  • the polymer foam precursor is continuously deposited on a continuous fiber web and then passed through a doctoring device such as a nip roller to force the polymer foam precursor to penetrate and saturate the fiber matrix.
  • a doctoring device such as a nip roller to force the polymer foam precursor to penetrate and saturate the fiber matrix.
  • the indoctrination of the polymer foam precursor is accomplished prior to any significant expansion due to a blowing reaction.
  • the blowing reaction itself may be initiated through the mixing of the materials making up the polymer foam precursor (as is the case in the example above for the hydrophilic polyurethane foam) or through subsequent initiation of a blowing agent within the polymer foam precursor.
  • Using a nip roller in this manner to force the penetration and saturation of the fiber matrix, and doing so at this stage of the reaction, allows for rapid production of a foam structure with fibers distributed throughout the foam (or if desired through a portion of the foam), and a continuous foam-fiber composite material having a uniform thickness that may later be cut into a desired length or shape.
  • the gap of the nip roller may be adjusted to control the thickness of the foam-fiber composite. Different thicknesses of the foam-fiber composite may also be obtained by using fiber webs with different thicknesses and adjusting the nip roller gap to correspond to these thicknesses.
  • the manufacturing process comprises dispensing the polymeric foam precursor (e.g., a hydrophilic polymerizing mixture of
  • the release liners, fiber matrix, and hydrophilic polymerizing mixture are then fed through a nip roller to force penetration of the hydrophilic polymerizing mixture into the fiber matrix.
  • This "sandwich" approach improves the quality of the composite material and provides for easy removal of the composite at the end of the casting line.
  • the top and bottom release liners are removed at the end of the production line when the foam-fiber composite material becomes tack free.
  • the foam- fiber composite material may then be dried in an oven or similar device.
  • the fiber matrix may have a basis mass in a range of 1-500 gsm (g/m " ) and, prior to combining with the polymer foam precursor, a loft, or caliper, in a range of about 0.5 to 50 mm. In these embodiments, average fiber diameter will typically be in a range of 5- 100 ⁇ . In some advantageous embodiments, the fiber matrix may have a basis mass in a range of 100-200 gsm and, prior to combining with the polymer foam precursor, a loft, or caliper, in a range of about 25 to 50 mm. In other advantageous embodiments, the fiber matrix may have a basis mass in a range of 10-125 gsm and, prior to combining with the polymer foam precursor, a loft, or caliper, in a range of about 0.5 to 6.0 mm.
  • the fiber web or matrix may be made up of multiple fiber layers or webs arranged one on top of the other or in a side-by-side
  • the resulting multi-layer web may be used as the fiber component during a single manufacturing process to obtain a single integrally formed foam-fiber composite material. If, however, the fiber layers have different properties (e.g., basis mass, loft, density, etc.), the resulting foam-fiber composite material will be formed with a plurality of cross-sectional regions of differing characteristics. Each of these regions may have a distribution of fibers that is different from the distribution of fibers in each other region. Some or all of these regions may have homogeneous fiber distributions and each region may have different physical
  • the foam-fiber composite material may have multiple distinct fiber layers which are intentionally of different basis masses along the width of the foam-fiber web and therefore create intentionally different physical characteristics of the foam-fiber web along its width.
  • one fiber web having a basis mass of 25 gsm may be placed along side or on top, or partially covering another fiber web having a basis mass of 75 gsm, either thermally bonded together or not bonded together, and then combined with the polymer foam precursor to obtain a gradient-type foam-fiber composite material.
  • the portion of the foam-fiber composite material having the fiber web with a basis mass of 75 gsm will be more dense than the portion having a fiber web with a basis mass of 25 gsm, but the fibers will nevertheless be distributed throughout the entire foam component without breaking the cross- linked molecular network of the foam, thereby allowing the foam to be monolithic.
  • the gradient nature of such a foam-fiber composite material is useful in the wound care setting because it allows for more rapid transfer of liquid exudates away from the wound via gradient capillary action.
  • Other parameters that may be varied from web to web in a multi-web composite include but are not limited to variations in fiber type, fiber diameter, fiber material or structure, and web or fabric structure (e.g., woven versus non-woven, bonded versus unbonded, etc). Any of these variations may be tailored to provide the desired characteristics in different cross- sectional regions of the resulting foam-fiber composite material.
  • the resultant foam-fiber composite material advantageously may have a thickness of approximately 1 - 50 mm for wound care or cosmetic applications.
  • Thicker foam-fiber composite materials may be produced by using a fiber component with a higher loft and by applying additional polymer foam precursor, and setting the nip roller to have a larger roll gap.
  • a range of 1 - 50 mm has been found to be advantageous in wound care applications.
  • Foam-fiber composite materials having a thickness from 20 - 40 mm are particularly useful in negative pressure wound therapy applications because of their increased strength.
  • Hydrophilic foam-fiber composite materials having the structure described above are well suited for wound care applications because they allow for rapid transfer of liquid exudates away from the wound via gradient capillarity. This promotes more rapid healing and reduces maceration of healthy skin surrounding the wound.
  • One or more surfaces of the composite material may also be coated with silicone or glycerin coatings, which can reduce sticking to the wound and therefore reduce pain and damage during changing of wound dressings.
  • releasable and/or unreleasable additives may be incoiporated into the foam structure, and the releasable additives may be later released when the foam-fiber composite material is exposed to a particular environment (e.g., immersion in a fluid) or applied to a surface (e.g., application to the skin as a bandage).
  • a particular environment e.g., immersion in a fluid
  • a surface e.g., application to the skin as a bandage
  • foam-fiber composite materials according to embodiments of the invention have been produced and have demonstrated improved tensile strength, tear strength, and swelling properties over unreinforced foam materials.
  • the composite materials produced have included structures with preordained gradient porosity or capillarity, and have been shown to be manufacturable in an inexpensive and efficient manner.
  • Table 1 lists the physical characteristics of a hydrophilic polyurethane foam-fiber composite materials prepared in accordance with one exemplary embodiment of the invention.
  • a hydrophilic prepolymer (specifically, PrePol)/aqueous solution mixture was poured onto a 2 mm thick non-woven fiber having a basis mass of 25 gsm.
  • the thickness of the final composite was controlled by making adjustments to the gap height of the nip roller. In this Example, the nip roller gap height was set to about 2 mm.
  • the fiber matrix (fiber component) of the resulting composite material was distributed throughout the entire foam component and was distributed substantially homogeneously throughout the foam.
  • the foam-fiber composite material was then subjected to a drying process to remove excess water.
  • a comparison was made with a 2.5 mm thick hydrophilic foam and the results are summarized in Table 1 .
  • MD Machine Direction of the fiber
  • TD Transverse Direction (i.e., Transverse to Machine Direction)
  • a dry hydrophilic foam-fiber composite material according to a first exemplary embodiment of the invention showed a 73% increase in tensile strength in a direction transverse to the machine direction (i.e., the direction along which the materials are drawn as the composite material is produced) and a 905% increase in tear strength in the same transverse direction compared to a dry unreinforced hydrophilic foam of approximately the same thickness. Further, these significant improvements in tensile and tear strength were achieved while maintaining approximately the same elongation characteristics in the same transverse direction.
  • the foam- fiber composite materials exhibit different tensile and elongation characteristics when tested across the web (transverse direction) than when tested along the web (machine direction). This is in contrast to the unreinforced foam specimen which does not show significant difference in machine direction and transverse direction results due to uniform cell structure of the foam. Dry foam- fiber composites tested in a transverse direction showed lower tensile and higher elongation values compared to similar samples tested in a machine direction. This, however, is a function of the particular fiber material used in this example and does not exemplify results for all other non-woven or woven structures, which may have comparable results for both the transverse and machine directions.
  • the foam-fiber composite material of Example 1 shows a 382-485% increase in tear strength even when wet, compared to a dry unreinforced hydrophilic foam of similar thickness, and a 2543%- 3106% increase in tear strength even wet, compared to a wet unreinforced hydrophilic foam.
  • the foam-fiber composite material according to Example 1 shows significant improvements in tensile strength and tear strength even when wet while maintaining adequate hydrophilic characteristics such that it may be advantageously used in wound dressing, medical, cosmetic and other applications where natural hydrophilic characteristics coupled with higher strength are required.
  • resulting foam-fiber composite materials can be used as a cleaning pad with or without antimicrobial agents, alone or attached to a substrate, to apply water based, water emulsion based, and oil based treatments such as would be useful in sanitizing or disinfecting applications.
  • Table 2 lists the physical characteristics of a hydrophilic foam-fiber composite mmaatteerriiaall pprreepploreedd iinn aaccccoorrddaannccee wwiitthh aannootthheerr eexxeemmppllaarryy eemmbbooddiimmeenntt ooff tthhee iinnvveennttiioonn..
  • Example 2 shows data from Example 2 tested in the machine direction (MD). As shown in Table 2, the foam-fiber composite material according to Example 2 exhibits the same trends as seen in Example 1. The foam-fiber composite material showed a 568% increase in tensile strength and a 463% increase in tear strength (machine direction) compared to the dry unreinforced hydrophilic foam of approximately the same thickness. Thus, the physical properties that are critical for wound care applications (tensile and tear strength) were far superior to those for the unreinforced hydrophilic foam of approximately the same thickness. EXAMPLES 3-7
  • Table 3 lists the physical properties of hydrophilic foam-fiber composite materials prepared in accordance with other exemplary embodiments of the invention.
  • multiple fiber layers were bonded together and a hydrophilic polymer foam precursor was poured onto the bonded fiber, and run through a nip roller to achieve a consistent thickness.
  • Each example has an approximate average thickness of 5 mm, and is compared to an
  • unreinforced hydrophilic foam material of approximately 5 mm.
  • Each fiber layer had a basis mass of either 25 gsm or 75 gsm and a loft ranging from 1-15 mm.
  • the plurality of fiber webs were bonded together to yield a single fiber web/matrix and, at the same time, produce the desired loft before the polymerizing mixture of prepolymer and aqueous solution was dispensed onto it.
  • a predetermined variable distribution of fibers throughout the foam was achieved by bonding together fiber layers having a different basis mass (e.g., 25 gsm and 75 gsm).
  • Table 3 Physical properties of dry hydrophilic foam-fiber composite materials prepared usin bonded multila er fiber webs.
  • Examples 3-7 are significantly higher than those of the unreinforced hydrophilic foam. Further, foam-fiber composite materials having fiber webs with a basis mass of 75 gsm show greater tensile and tear strength properties than those having fiber webs with a basis mass of 25 gsm.
  • Table 4 lists the physical properties of a hydrophilic foam-fiber composite material according to yet another exemplary embodiment of the invention.
  • a hydrophilic polyurethane foam-fiber composite material was prepared as above but with a thicker fiber matrix such as may be used for negative pressure wound therapy (NPWT) applications.
  • the foam-fiber composite material in this example was prepared by dispensing a mixture of prepolymer and aqueous solution onto a rolled fiber matrix of approximately 50 mm thickness, and then fed through a nip roller having a roll gap of approximately 25 mm.
  • the foam-fiber composite material was sandwiched between two release liners as described above. The two release liners were removed at the end of the production line and the foam-fiber composite material was dried in an oven to remove excess water.
  • the foam-fiber composite material according to this exemplary embodiment of the invention shows much greater tear strength for the dry foam-fiber composite material than the unreinforced dry hydrophilic foam in both the transverse and machine directions of the fiber web while maintaining similar absorbent characteristics.
  • the tensile and tear strength values of wet fiber reinforced specimens were increased by 78% and 493% respectively in the transverse direction compared to wet unreinforced foam materials.
  • the improvements in machine direction were 109% and 622% respectively.
  • a thicker foam-fiber composite material is useful in negative pressure wound therapy applications because it is able to withstand forces inherent in such applications where a controlled sub-atmospheric or negative pressure is applied to the wound bed with a tube threaded through the dressing via a vacuum source to promote the moist wound healing process of acute or chronic wounds.
  • Examples 9A-E are foam-fiber composite materials according to additional embodiments of the invention. These embodiments comprise latex and other emulsions to produce the foam component of the foam-fiber composite materials. These emulsions and their loading level in the aqueous solution are shown in the Table 5. These aqueous emulsion solutions were mixed with PrePol prepolymer and MDI based prepolymers and poured onto thin fiber webs to obtain foam-fiber composite materials.
  • the non-volatile solid content of the above emulsions may be in the range of 20-70 wt %.
  • Products made from the foam-fiber composites described above have utility in a number of applications, including, but not limited to, dressings for wound care, cosmetic, household cleaning/disinfecting applications.
  • One advantage of the medical grade foam-fiber composite materials is the rapid transfer of exudate fluids away from the wound to facilitate healing of wounds, especially wound tunnel and deep wound cavity treatments and chronic wounds that may be a byproduct of diabetes and burns.
  • the foam-fiber composite materials described herein have further utility in that they are substantially clean as a result of their resistance to shedding debris, allow for dressing changes without the pain of sticking to the wound surface, and reduce maceration of good skin in the area surrounding the wound.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Textile Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Nonwoven Fabrics (AREA)

Abstract

La présente invention concerne un matériau composite de mousse et de fibres, fait d'une structure de mousse monolithique comportant un matériau polymère et une toile de fibres comportant une pluralité de fibres disposées sensiblement sur toute la structure de mousse.
EP10819437.4A 2009-09-23 2010-09-23 Structures composites de fibres et de mousse, et procédés de fabrication Withdrawn EP2480408A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24507609P 2009-09-23 2009-09-23
US12/887,943 US20110070423A1 (en) 2009-09-23 2010-09-22 Foam and Fiber Composite Structures and Methods of Manufacture
PCT/US2010/049951 WO2011038084A1 (fr) 2009-09-23 2010-09-23 Structures composites de fibres et de mousse, et procédés de fabrication

Publications (2)

Publication Number Publication Date
EP2480408A1 true EP2480408A1 (fr) 2012-08-01
EP2480408A4 EP2480408A4 (fr) 2014-01-22

Family

ID=43796198

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10819437.4A Withdrawn EP2480408A4 (fr) 2009-09-23 2010-09-23 Structures composites de fibres et de mousse, et procédés de fabrication

Country Status (2)

Country Link
EP (1) EP2480408A4 (fr)
WO (1) WO2011038084A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4417243A1 (fr) 2023-02-15 2024-08-21 Heraeus Medical GmbH Implant pour libération prolongée de médicament

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL226081B1 (pl) * 2012-02-16 2017-06-30 Politechnika Łódzka Material medyczny i sposob jego wytwarzania oraz zastosowanie materialu medycznego
WO2014142959A1 (fr) * 2013-03-15 2014-09-18 Tempur-Pedic Management, Llc Composite de mousse et ses procédés de fabrication
TWI594742B (zh) * 2013-07-05 2017-08-11 Wound covering and method of making the same
US10729600B2 (en) 2015-06-30 2020-08-04 The Procter & Gamble Company Absorbent structure
EP3370673B1 (fr) 2015-11-04 2022-03-30 The Procter & Gamble Company Structure absorbante
HUE057989T2 (hu) * 2015-11-04 2022-06-28 Procter & Gamble Nedvszívó szerkezetet tartalmazó nedvszívó árucikk
GB201712162D0 (en) * 2017-07-28 2017-09-13 Smith & Nephew Absorbent article and method of manufacture

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2115237A1 (de) * 1971-03-30 1972-10-05 Johann Otto Zentgraf KG, 8019 Steinhöring Bürstenschwamm oder Schwammbürstentücher mit stark gewinkelten, gewellten Bürstenfasern, im Schaumstoff eingeschlossen
EP1600096A2 (fr) * 2004-05-26 2005-11-30 The Clorox Company Substrat comportant une mousse
US20070079462A1 (en) * 2005-10-06 2007-04-12 Haskett Thomas E Scouring web and method of making
DE102006005984A1 (de) * 2006-02-08 2007-08-09 Carl Freudenberg Kg Reinigungstuch
WO2007101881A2 (fr) * 2006-03-09 2007-09-13 Basf Se Composite en couches composé d'une mousse de résine de mélamine à cellules ouvertes et d'un non-tissé ou d'un tissu de fibres de mélamine
WO2009007924A2 (fr) * 2007-07-12 2009-01-15 Kimberly-Clark Worldwide, Inc. Éponge à main gonflante avec indicateur de changement de couleur
WO2009007926A2 (fr) * 2007-07-12 2009-01-15 Kimberly-Clark Worldwide, Inc. Éponge à main gonflante avec indicateur de changement de couleur
WO2010118320A2 (fr) * 2009-04-10 2010-10-14 3M Innovative Properties Company Éponge de nettoyage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1243545A (fr) * 1958-10-06 1960-10-14 Owens Corning Fiberglass Corp Produit fibro-cellulaire et son procédé de fabrication
US3962388A (en) * 1973-01-02 1976-06-08 Sun Research And Development Co. Method of producing a foam fibrillated web
US4450833A (en) * 1981-12-02 1984-05-29 Brooks William R Method of dimensioning a polyurethane foam bandage
US5338766A (en) * 1993-03-26 1994-08-16 The Procter & Gamble Company Superabsorbent polymer foam
US6224961B1 (en) * 1997-08-01 2001-05-01 The Procter & Gamble Company Absorbent macrostructure made from mixtures of different hydrogel-forming absorbent polymers for improved fluid handling capability
US20060246272A1 (en) * 2005-04-29 2006-11-02 Zhang Xiaomin X Thermoplastic foam composite

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2115237A1 (de) * 1971-03-30 1972-10-05 Johann Otto Zentgraf KG, 8019 Steinhöring Bürstenschwamm oder Schwammbürstentücher mit stark gewinkelten, gewellten Bürstenfasern, im Schaumstoff eingeschlossen
EP1600096A2 (fr) * 2004-05-26 2005-11-30 The Clorox Company Substrat comportant une mousse
US20070079462A1 (en) * 2005-10-06 2007-04-12 Haskett Thomas E Scouring web and method of making
DE102006005984A1 (de) * 2006-02-08 2007-08-09 Carl Freudenberg Kg Reinigungstuch
WO2007101881A2 (fr) * 2006-03-09 2007-09-13 Basf Se Composite en couches composé d'une mousse de résine de mélamine à cellules ouvertes et d'un non-tissé ou d'un tissu de fibres de mélamine
WO2009007924A2 (fr) * 2007-07-12 2009-01-15 Kimberly-Clark Worldwide, Inc. Éponge à main gonflante avec indicateur de changement de couleur
WO2009007926A2 (fr) * 2007-07-12 2009-01-15 Kimberly-Clark Worldwide, Inc. Éponge à main gonflante avec indicateur de changement de couleur
WO2010118320A2 (fr) * 2009-04-10 2010-10-14 3M Innovative Properties Company Éponge de nettoyage

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011038084A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4417243A1 (fr) 2023-02-15 2024-08-21 Heraeus Medical GmbH Implant pour libération prolongée de médicament

Also Published As

Publication number Publication date
WO2011038084A1 (fr) 2011-03-31
EP2480408A4 (fr) 2014-01-22

Similar Documents

Publication Publication Date Title
US20110070423A1 (en) Foam and Fiber Composite Structures and Methods of Manufacture
WO2011038084A1 (fr) Structures composites de fibres et de mousse, et procédés de fabrication
US9000252B2 (en) Wound dressing
KR101633521B1 (ko) 다층 복합 재료, 이의 제조 및 이의 용도
EP1923077B1 (fr) Pansement multicouche absorbant avec une couche hydrophile en contact de plaies
CN108348361B (zh) 吸收结构
EP2393524B1 (fr) Matériaux de pansement pour plaie en mousse absorbante
RU2565431C2 (ru) Композитное многослойное гемостатическое устройство
JP5514816B2 (ja) 創傷被覆材
CN102596560B (zh) 医疗制品及使用可混溶组合物进行制备的方法
KR100937816B1 (ko) 친수성 폼 드레싱재의 제조방법 및 제조된 친수성 폼드레싱재
US20080014386A1 (en) Cohesive articles with a foam layer
EP2039328A1 (fr) Matériau de recouvrement d'une plaie
WO2010026251A1 (fr) Article pour le soin des plaies contenant une proportion de fibres naturelles modifiées ou de fibres synthétiques
WO2006073757A2 (fr) Mousse absorbante contenant des fibres
EP2593058A1 (fr) Article pour le traitement de plaies par l'utilisation de microfibres contenant une pression négative
JP2013517859A (ja) 柔軟性のある高吸収性を有する材料
KR101202875B1 (ko) 메쉬 필름을 포함하는 친수성 폴리우레탄 폼 드레싱재 및 그의 제조방법
DK1885550T3 (en) MECHANICAL STRENGTH Absorbing non-woven fibrous mats
EP3960025B1 (fr) Corps stratifié de fibres et son procédé de production
CN115023205A (zh) 用于伤口敷料的双涂层
GB2464970A (en) Wound dressing comprising fibrous plugs
KR20180075812A (ko) 항균성 폴리우레탄 폼 드레싱재 및 이의 제조방법
CN1224372A (zh) 吸收性制鞋材料
CN118055749A (zh) 泡沫-气垫的组合及其使用方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120229

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140103

RIC1 Information provided on ipc code assigned before grant

Ipc: B32B 5/28 20060101ALI20131218BHEP

Ipc: B32B 5/22 20060101AFI20131218BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ESSENTRA POROUS TECHNOLOGIES CORP.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160401